Drug‐Disease Interaction and Time‐Dependent Population Pharmacokinetics of Isatuximab in Relapsed/Refractory Multiple Myeloma Patients

por Fau, Jean‐Baptiste, El‐Cheikh, Raouf, Brillac, Claire, Koiwai, Kimiko, Mace, Nathalie, Campana, Frank, Semiond, Dorothee, Nguyen, Laurent
Publicado 2020

A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours

por Schram, Alison M., Gandhi, Leena, Mita, Monica M., Damstrup, Lars, Campana, Frank, Hidalgo, Manuel, Grande, Enrique, Hyman, David M., Heist, Rebecca S.
Publicado 2018

Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma

por Richardson, Paul G., Facon, Thierry, Bensinger, William I., Leleu, Xavier, Campana, Frank, Macé, Sandrine, Chiron, Marielle, van de Velde, Helgi, Mikhael, Joseph
Publicado 2021

Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab

por Martin, Thomas G., Corzo, Kathryn, Chiron, Marielle, van de Velde, Helgi, Abbadessa, Giovanni, Campana, Frank, Solanki, Malini, Meng, Robin, Lee, Helen, Wiederschain, Dmitri, Zhu, Chen, Rak, Alexey, Anderson, Kenneth C.
Publicado 2019

Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma

por Hulin, Cyrille, Beksac, Meral, Goodman, Hugh J., Spicka, Ivan, Alegre, Adrian, Prince, Miles, Campana, Frank, Finn, Greg, Le-Guennec, Solenn, Macé, Sandrine, Muccio, Stéphane, Tavernier, Alexandra, Rouchon, Marie-Claude, Richardson, Paul G.
Publicado 2021

Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma

por Usmani, Saad Z., Karanes, Chatchada, Bensinger, William I., D’Souza, Anita, Raje, Noopur, Tuchman, Sascha A., Sborov, Douglas, Laubach, Jacob P., Bianchi, Giada, Kanagavel, Dheepak, Saleem, Rao, Dubin, Franck, Campana, Frank, Richardson, Paul G.
Publicado 2021

Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis

por Dimopoulos, Meletios A., Leleu, Xavier, Moreau, Philippe, Richardson, Paul G., Liberati, Anna Marina, Harrison, Simon J., Miles Prince, H., Ocio, Enrique M., Assadourian, Sylvie, Campana, Frank, Malinge, Laure, Sémiond, Dorothée, van de Velde, Helgi, Yong, Kwee
Publicado 2020

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

por Schjesvold, Fredrik, Richardson, Paul G., Facon, Thierry, Alegre, Adrián, Spencer, Andrew, Jurczyszyn, Artur, Sunami, Kazutaka, Frenzel, Laurent, Min, Chang-Ki, Guillonneau, Sophie, Lin, Peggy L., Le-Guennec, Solenn, Campana, Frank, van de Velde, Helgi, Bensfia, Samira, Bringhen, Sara
Publicado 2021

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

por Schjesvold, Fredrik, Richardson, Paul G., Facon, Thierry, Alegre, Adrián, Spencer, Andrew, Jurczyszyn, Artur, Sunami, Kazutaka, Frenzel, Laurent, Min, Chang-Ki, Guillonneau, Sophie, Lin, Peggy L., Le-Guennec, Solenn, Campana, Frank, van de Velde, Helgi, Bensfia, Samira, Bringhen, Sara
Publicado 2022

Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study

por Extra, Jean-Marc, Antoine, Eric C., Vincent-Salomon, Anne, Delozier, Thierry, Kerbrat, Pierre, Bethune-Volters, Anne, Guastalla, Jean-Paul, Spielmann, Marc, Mauriac, Louis, Misset, Jean-Louis, Serin, Daniel, Campone, Mario, Hebert, Christophe, Remblier, Céline, Bergougnoux, Loïc, Campana, Frank, Namer, Moïse
Publicado 2010

Subgroup analysis of ICARIA‐MM study in relapsed/refractory multiple myeloma patients with high‐risk cytogenetics

por Harrison, Simon J., Perrot, Aurore, Alegre, Adrian, Simpson, David, Wang, Ming Chung, Spencer, Andrew, Delimpasi, Sosana, Hulin, Cyrille, Sunami, Kazutaka, Facon, Thierry, Vlummens, Philip, Yong, Kwee, Campana, Frank, Inchauspé, Marlène, Macé, Sandrine, Risse, Marie‐Laure, van de Velde, Helgi, Richardson, Paul
Publicado 2021

P009: Improved Overall Survival with First-Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHE...

por Hutchings, Martin, Ansell, Stephen M., Connors, Joseph M., Kim, Won Seog, Gallamini, Andrea, Ramchandren, Radhakrishnan, Friedberg, Jonathan W., Advani, Ranjana, Evens, Andrew M., Smolewski, Piotr, Savage, Kerry J., Bartlett, Nancy L., Eom, Hyeon-Seok, Abramson, Jeremy S., Dong, Cassie, Campana, Frank, Fenton, Keenan, Puhlmann, Markus, Straus, David J., Radford, John
Publicado 2022